A detailed history of Royce & Associates LP transactions in Accuray Inc stock. As of the latest transaction made, Royce & Associates LP holds 1,882,369 shares of ARAY stock, worth $3.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,882,369
Previous 2,882,536 34.7%
Holding current value
$3.65 Million
Previous $5.25 Million 35.42%
% of portfolio
0.03%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$1.41 - $2.49 $1.41 Million - $2.49 Million
-1,000,167 Reduced 34.7%
1,882,369 $3.39 Million
Q2 2024

Aug 13, 2024

SELL
$1.49 - $2.43 $583,965 - $952,372
-391,923 Reduced 11.97%
2,882,536 $5.25 Million
Q1 2024

May 13, 2024

BUY
$2.37 - $2.94 $97,982 - $121,548
41,343 Added 1.28%
3,274,459 $8.09 Million
Q4 2023

Feb 12, 2024

BUY
$2.44 - $3.08 $471,652 - $595,364
193,300 Added 6.36%
3,233,116 $9.15 Million
Q3 2023

Nov 09, 2023

BUY
$2.63 - $4.26 $383,141 - $620,601
145,681 Added 5.03%
3,039,816 $8.27 Million
Q2 2023

Aug 07, 2023

SELL
$2.7 - $3.97 $283,500 - $416,850
-105,000 Reduced 3.5%
2,894,135 $11.2 Million
Q1 2023

May 04, 2023

BUY
$2.06 - $3.18 $397,374 - $613,422
192,900 Added 6.87%
2,999,135 $8.91 Million
Q4 2022

May 23, 2023

SELL
$1.88 - $2.4 $362,652 - $462,960
-192,900 Reduced 6.43%
2,806,235 $5.87 Million
Q4 2022

Feb 13, 2023

BUY
$1.88 - $2.4 $148,332 - $189,360
78,900 Added 2.89%
2,806,235 $5.87 Million
Q3 2022

Nov 03, 2022

BUY
$1.92 - $2.97 $152,256 - $235,521
79,300 Added 2.99%
2,727,335 $5.67 Million
Q2 2022

Aug 04, 2022

BUY
$1.76 - $3.52 $416,394 - $832,789
236,588 Added 9.81%
2,648,035 $5.19 Million
Q1 2022

May 05, 2022

BUY
$3.16 - $4.81 $1.54 Million - $2.35 Million
488,582 Added 25.41%
2,411,447 $7.98 Million
Q4 2021

Feb 07, 2022

BUY
$3.72 - $5.88 $607,048 - $959,527
163,185 Added 9.27%
1,922,865 $9.17 Million
Q3 2021

Nov 10, 2021

SELL
$3.5 - $4.56 $684,561 - $891,885
-195,589 Reduced 10.0%
1,759,680 $6.95 Million
Q2 2021

Aug 06, 2021

BUY
$4.24 - $5.51 $196,206 - $254,975
46,275 Added 2.42%
1,955,269 $8.84 Million
Q1 2021

May 10, 2021

BUY
$4.25 - $5.89 $75,050 - $104,011
17,659 Added 0.93%
1,908,994 $9.45 Million
Q4 2020

Feb 08, 2021

BUY
$2.53 - $4.71 $37,950 - $70,650
15,000 Added 0.8%
1,891,335 $7.89 Million
Q3 2020

Nov 12, 2020

SELL
$1.98 - $2.74 $168,300 - $232,900
-85,000 Reduced 4.33%
1,876,335 $4.5 Million
Q2 2020

Aug 07, 2020

SELL
$1.7 - $2.56 $331,330 - $498,944
-194,900 Reduced 9.04%
1,961,335 $3.98 Million
Q1 2020

May 12, 2020

BUY
$1.35 - $4.28 $131,633 - $417,325
97,506 Added 4.74%
2,156,235 $4.1 Million
Q4 2019

Feb 06, 2020

BUY
$2.56 - $3.08 $478,507 - $575,704
186,917 Added 9.99%
2,058,729 $5.81 Million
Q3 2019

Nov 13, 2019

BUY
$2.58 - $4.14 $464,400 - $745,200
180,000 Added 10.64%
1,871,812 $5.19 Million
Q2 2019

Aug 12, 2019

SELL
$3.54 - $4.64 $35,400 - $46,400
-10,000 Reduced 0.59%
1,691,812 $6.55 Million
Q1 2019

May 09, 2019

SELL
$3.32 - $5.28 $373,500 - $594,000
-112,500 Reduced 6.2%
1,701,812 $8.12 Million
Q4 2018

Feb 11, 2019

SELL
$3.31 - $5.24 $794,400 - $1.26 Million
-240,000 Reduced 11.68%
1,814,312 $6.19 Million
Q3 2018

Nov 13, 2018

SELL
$3.48 - $4.6 $158,340 - $209,299
-45,500 Reduced 2.17%
2,054,312 $9.24 Million
Q2 2018

Aug 09, 2018

BUY
$3.85 - $5.15 $522,772 - $699,292
135,785 Added 6.91%
2,099,812 $8.61 Million
Q1 2018

May 14, 2018

BUY
$4.5 - $5.9 $456,075 - $597,965
101,350 Added 5.44%
1,964,027 $9.82 Million
Q4 2017

Feb 09, 2018

BUY
$3.95 - $5.3 $711,395 - $954,530
180,100 Added 10.7%
1,862,677 $8.01 Million
Q3 2017

Nov 13, 2017

BUY
$3.9 - $4.6 $25,350 - $29,899
6,500 Added 0.39%
1,682,577 $6.73 Million
Q2 2017

Aug 07, 2017

BUY
N/A
1,676,077
1,676,077 $7.96 Million

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $182M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.